Search | Clinical Trials Finder

Conditions: Posttraumatic Stress Disorder, Traumatic Brain Injury
Interventions: Reconsolidation of Traumatic Memories (RTM), Prolonged Exposure (PE); Behavioral
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Immediate Placement of Straumann BLX Implants in Molar Extraction Sockets
Interventions: Immediate placement non-occlusal loading molar implant (Straumann BLX 6.5mm), Delayed placement non-occlusal loading molar implant (Straumann BLX 5.0mm); Device
Lead sponsor: Ahmad Kutkut; Other
Eligibility: 22 Years to 78 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Diabetes Mellitus, Type 1
Interventions: Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte globulin, Daclizumab or basiliximab, Sirolimus, Tacrolimus, Etanercept; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 3
States / cities: San Francisco, California • Chicago, Illinois • Minneapolis, Minnesota

Conditions: Chronic Rhinosinusitis
Interventions: Pre-treatment Sinus CT Scan, Post-treatment Sinus CT Scan; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity, Atypical Depression
Interventions: Chromium Picolinate; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Psychomotor Agitation, Behavioral Disorder
Interventions: Peer-Support Enhanced Agitation Code Team (PACT); Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 57,870 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Shock, Critical Illness
Interventions: Cheetah NICOM; Device
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Acute Coronary Syndrome, Coronary Artery Disease
Interventions: Ticagrelor- Delayed Administration, Ticagrelor- Immediate Administration, Optical Coherence Tomography; Drug · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 79 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Scar Tissue, Hypertrophic Scar, Hypertrophic Scar of Upper Arm (Disorder), Hypertrophic Surgical Scar, Dry Needling
Interventions: True dry needling, Sham dry needling; Other
Lead sponsor: Iran University of Medical Sciences; Other
Eligibility: 20 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Spinal Cord Injury
Interventions: SCI Reinvention Protocol Participants, Waitlist Group; Behavioral · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 100 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Meningococcal Immunisation (Healthy Volunteers)
Interventions: Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine, Meningococcal Group B vaccine (Trumenba®), Meningococcal group B vaccine (Bexsero®); Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 13 Years to 26 Years
Enrollment: 570 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 29
States / cities: Birmingham, Alabama • San Diego, California • Bardstown, Kentucky + 20 more

Conditions: BPH, Urinary Incontinence
Interventions: Group preoperative pelvic floor training; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 90 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: CD 19+ Acute Leukemia
Interventions: T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC); Biological
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 1 Year to 30 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2033
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Neoplasms, Neoplasm Metastasis
Interventions: Growing Resiliency And CouragE with Cancer™ (GRACE); Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Social Anxiety Disorder
Interventions: Cognitive Behavioral Group Therapy, Mindfulness-Based Stress Reduction; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non Small Cell Lung Cancer
Interventions: Photodynamic Therapy, Argon Plasma Coagulation; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Distress, Emotional, Depression, Anxiety, Fatigue, Pain, Insomnia
Interventions: Individualized Evidence-Based Therapy in Cancer (Patients and Caregivers), Training in Individualized Evidence-Based Therapy in Cancer (Therapists); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prostate Cancer
Interventions: blood draw; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 30 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Retinoblastoma, Retinal Neoplasm
Interventions: Enucleation, Vincristine, Carboplatin, Focal Therapies, External Beam Radiation, Vincristine and Topotecan, Vincristine + Carboplatin + Etoposide, vincristine, cyclophosphamide, and doxorubicin, Vincristine, Carboplatin and Etoposide, Periocular carboplatin, G-CSF; Procedure · Drug · Radiation + 1 more
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Alzheimer Disease
Interventions: Challenge A - low calorie Ensure®, Challenge B - Ensure® plus ketone esters (KE), PET Scan, Cognitive Testing - FCSRT, Story Recall, BVRT, CogState One Card Learning; Dietary Supplement · Procedure · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Type 1 Diabetes
Interventions: Cognitive Behavioral Therapy for Diabetes Distress (CBT-DD) with Continuous Glucose Monitoring, Continuous Glucose Monitoring (CGM); Behavioral · Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma
Interventions: Trabectedin, Ipilimumab, Nivolumab; Drug
Lead sponsor: Sarcoma Oncology Research Center, LLC; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2031
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Breast Cancer
Interventions: NIR/US Diagnostic Group, NIR/US Neoadjuvant Chemotherapy Group, NIR/US Process Validation Group; Other
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Bipolar Disorder, Psychosis
Interventions: BrainWorks, Computer Control; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Belmont, Massachusetts

Search by objective public record fields.

RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD)

Immediate vs Delayed Placement of Straumann BLX Implants in Molar Extraction Sockets

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study

Effects of Chromium Picolinate on Food Intake

Clinical Trial of Peer Support in the ED (PCORI)

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study

Effectiveness of Dry Needling in Linear Scar Tissue

Re-Inventing Yourself After Spinal Cord Injury

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer

Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder

Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction

Training in Evidence-based Treatments in Psycho-Oncology

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

The Brain Ketone Body Challenge Imaging Study

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Treatment to Enhance Cognition in Bipolar Disorder